Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Freeport-McMoRan Inc (FCX) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance

Freeport-McMoRan IncTrade
Norwegian Cruise Line Holdings LtdTrade

Price performance (Past 24H)

Key statistics

Freeport-McMoRan Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? Freeport-McMoRan Inc trades at $72.85 (market cap $102.16B), while Norwegian Cruise Line Holdings Ltd trades at $15.5 (market cap $7.11B). The key difference: Freeport-McMoRan Inc is far larger — about 14.4× Norwegian Cruise Line Holdings Ltd's market cap, and Freeport-McMoRan Inc pays a 0.84% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freeport-McMoRan Inc for 69 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.

FCXNCLH
Market Cap
$102.16B$7.11B
Volume
9,047,97122,683,268
Sector
Basic MaterialsConsumer Cyclical
52-Week High
$79.91$25.02
52-Week Low
$38.65$14.12
Typical Hold Time
69 Days68 Days
Enterprise Value
$108.44B$21.93B
Dividend Yield
0.84%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Freeport-McMoRan Inc

FCX trades at $71.87, down 0.97% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $73.27. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue for 2025 was $25.92 billion, with net income of $2.20 billion and a net margin of 11.38%. Recent news highlights strong copper demand driven by AI and data center growth, positioning FCX to benefit from favorable market trends.

The outlook for FCX is positive, supported by robust copper demand and expansion projects, but risks include rising production costs and potential regulatory investigations. Analyst sentiment is predominantly bullish, with 61% recommending buy. The stock offers growth potential from commodity tailwinds, though investors should monitor cost pressures and execution of growth initiatives.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings (NCLH) trades at $15.05, down 2.97% on the day, with a neutral technical signal and bearish moving average trend. The company reported strong earnings beats in recent quarters, with Q3 2026 expected to exceed guidance at $0.914 EPS. Fundamentals show robust revenue growth to $9.83B in 2025, though net income margin compressed to 4.3%. Recent news highlights yield pressure and a $950M senior notes offering.

NCLH presents a mixed outlook: valuation appears attractive with a P/E of 9.39 and analyst consensus target of $20.86, implying upside. However, high debt levels, net yield pressures, and volatile cash flows pose risks. The stock offers potential for recovery if operational improvements and pricing strategies stabilize profitability through 2027.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FCX
46% Buy54% Sell
Avg holding period · 69 Days
NCLH
100% Buy0% Sell
Avg holding period · 68 Days

Top news

Latest headlines on both assets

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX →

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH →